The global central lab market size, in terms of value, is estimated to be around US$ 2,543.9 million in 2023. During the market forecast period from 2023 to 2033, the overall market is anticipated to expand at a CAGR of 5.8%. By the end of 2033, the net worth of total business by central labs worldwide could reach up to US$ 4,473.5 million.
Central Lab Market Trends
| Report Attribute | Details |
|---|---|
| Central Lab Market Share (2023) | US$ 2,543.9 million |
| Market Anticipated Forecast Value (2033) | US$ 4,473.5 million |
| Market Projected Growth Rate (2023 to 2033) | 5.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to our market survey, the demand for central lab services surged at 4.1% CAGR from 2018 to 2022 with a market valuation of US$ 2,422.7 million. During the evaluation period, the worldwide central lab market was projected to have strong growth potential due to rising pharmaceutical and biotechnology company activities.
| Attributes | Details |
|---|---|
| Central Lab Market Size (2018) | US$ 1,980.8 million |
| Market Size (2022) | US$ 2,422.7 million |
| Market (CAGR 2018 to 2022) | 4.1% |
The importance of central labs surged during the pandemic years as they witnessed tremendous opportunities regarding research and development for curbing COVID-19 spread. Also, central labs were much preferred for genetic sequencing since they have better and more advanced technology, ultimately setting the trend for the future.
The need for central laboratories has increased since pharmaceutical companies always look for methods to lower the cost of medication research and manufacturing. So, giant pharmaceutical businesses are also making significant investments to establish facilities for providing central lab equipment and services in recent years.
To combat the rising burden of many chronic illnesses, several government health institutions have also come forward to encourage entrepreneurs to set up central labs. Throughout the projected period, government support is anticipated to serve as a driving force for clinical central laboratory market expansion.
In light of strict criteria for the standard of lab data in trials, central labs have recently emerged as the best choices for clinical trials. Also, the existence of advanced technologies and the inability of local laboratories to organize necessary tests has surged the demand for central labs in recent years.
Automation of procedures has boosted the central lab output as it requires less human interaction and performs better all around. Additionally, they have increased the scope of their services by integrating technological and software advancements.
Principal Consultant
Clinical trials in any centralized laboratory services industry are one of the most expensive procedures that limit market expansion to certain degrees. Additionally, the necessity for significant capital expenditures to set up and run central lab equipment and services is restricting market expansion.
As central laboratory testing services deal with the healthcare sector, sufficient medical infrastructure remains a crucial challenge for the overall market. Also, regulatory difficulties have hindered the development of clinical central laboratory industry trends.
Owing to numerous clinical testing central labs, the United States has dominated the global market for a very long time. In 2022, the total revenue generated by the market players present in the country was around US$ 1,010.2 million. The United States market is expected to expand at a healthy rate during the forecast period with rising drug research and development activities.
In 2022, Germany contributed roughly US$ 112 million in the total revenue of US$ 456 million generated by central lab services in Europe. An increase in genetic disorders and clinical testing services cases is poised to keep the German market profitable in the coming days. Also, some advanced central labs, including Eurofins in Luxembourg, are expected to keep the central laboratory testing services trends intact.
In the table below, we provide an estimated market share of the performing three countries in different geographical locations. The United States remains the leading market for central laboratory testing services trends. Meanwhile, Germany and Japan lead Europe and Asia markets, respectively, in demand for clinical trials.
| Regional Market Comparison | Global Market Share in Percentage (2023) |
|---|---|
| United States | 51% |
| Germany | 6% |
| Japan | 3% |
The market in the United Kingdom could progress at a higher rate than in Germany. The growing popularity of Alzheimer’s therapeutics services in the country has substantially improved the central lab outsourcing market in recent years. In addition, strengthening the medical tourism sector is projected to drive the market at a higher rate during the forecast years.
China is the leading market for central laboratory testing services in Asia, poised to grow 7.6% through 2033. China is also likely to witness a higher growth rate in demand for lab accessories used in central labs in the next ten years. Also, favorable support from the Chinese government for improving the country's central laboratory services market outlook is expected to drive this trend.
The need for central labs has significantly increased in India with rising government and pharmaceutical company investments in the development of innovative drugs. However, regulatory difficulties and the scarcity of central labs in many emerging and impoverished locations in India are still leading concerns for market growth.
The table below represents the projected growth rates for the expansion of regional markets as per central lab market statistics and forecast. Though Asian countries like China and India are likely to witness higher growth rates, the United Kingdom and Australia are anticipated to experience remarkable growth through 2033.
| Regional Markets | CAGR (2023 to 2033) |
|---|---|
| United Kingdom | 5.1% |
| China | 7.6% |
| India | 6% |
| Australia | 4.9% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The incidence of chronic illnesses, including cancer, Alzheimer's disease, and diabetes, is on the rise and could drive the business of the central labs. This trend demonstrates the rising demand for biomarkers that form the leading service segment and generated almost US$ 772.5 million in 2022.
| Attributes | Details |
|---|---|
| Top Service Type | Biomarker |
| Market Share in 2023 | 39% |
Central labs are primarily located where most clinical studies are carried out, limiting the business opportunities for the central diagnostic laboratories market. So, new drug discovery is the primary activity in central labs, resulting in the biotechnology sector being the dominant end-user segment for the overall market. However, the rising need for novel medications and vaccines after the pandemic has strengthened the market position of the pharmaceutical segment.
| Attributes | Details |
|---|---|
| Top End User | Biotechnology |
| Market Share in 2023 | 42% |
Multinational corporations are noticeably at the forefront of the adoption of services provided by central labs because of the many advantages they provide. Furthermore, to enhance the services provided by the central lab business, global market players are adopting collaborations and agreements as essential development tactics.
Emmes is a renowned organization that provides full-service clinical research with a focus on rare diseases. Likewise, the ICON plc acquired MolecularMD laboratory in February 2019. It is a molecular diagnostic specialty laboratory that facilitates discovering, developing, and commercializing discovered medicines for cancer treatment. It aims to expand ICON's testing platforms, including next-generation sequencing and immunohistochemistry, by improving the laboratory's ability in molecular diagnostic testing.
Regional expansion to Asian countries is a strategy for global businesses to expand after the saturation of current distribution channels. Many central lab service providers in the United States are employing this strategy to draw in additional clients from adjacent countries and Latin America.
The Alba Campus in Livingston, Scotland, expanded its laboratory and operational capabilities starting in June 2021, according to a statement from Q2 Solutions. Alba Camus is a premier global provider of clinical trial services for pharmaceutical laboratories and supports new growth areas for biopharma and pharma clients globally. Besides being a wholly owned subsidiary of IQVIA, it is expanding its capabilities for genomics, flow cytometry, and translational science laboratory services.
Recent Development
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 5.8% from 2023 to 2033 |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ million or billion, Volume in Kilotons, and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization & Pricing | Available Upon Request |
The global central laboratory market value in 2023 is roughly US$ 2,543.9 million.
The global market is likely to record a 5.8% CAGR through 2033.
The global central lab market value could reach US$ 4,473.5 million by 2033.
The United States alone accounts for over 50% of the global market.
China is predicted to witness a CAGR of 7.6% through 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Service Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Service Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service Type, 2023 to 2033 5.3.1. Genetic Services 5.3.2. Biomarker Services 5.3.3. Microbiology Services 5.3.4. Anatomic Pathology/Histology 5.3.5. Specimen Management & Storage 5.3.6. Special Chemistry Services 5.3.7. Others 5.4. Y-o-Y Growth Trend Analysis By Service Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Service Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 6.3.1. Pharmaceutical Companies 6.3.2. Biotechnology Companies 6.3.3. Academic and Research Institutes 6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Service Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Service Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Service Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Service Type 9.3.3. By End User 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. UK 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Service Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Service Type 10.3.3. By End User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Service Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Service Type 11.3.3. By End User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Service Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Service Type 12.3.3. By End User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Service Type 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Service Type 13.3.3. By End User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Service Type 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Service Type 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Service Type 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Service Type 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Service Type 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Service Type 15.4.2.2. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Service Type 15.5.2.2. By End User 15.6. UK 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Service Type 15.6.2.2. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Service Type 15.7.2.2. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Service Type 15.8.2.2. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Service Type 15.9.2.2. By End User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Service Type 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Service Type 15.11.2.2. By End User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Service Type 15.12.2.2. By End User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Service Type 15.13.2.2. By End User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Service Type 15.14.2.2. By End User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Service Type 15.15.2.2. By End User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Service Type 15.16.2.2. By End User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Service Type 15.17.2.2. By End User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Service Type 15.18.2.2. By End User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Service Type 15.19.2.2. By End User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Service Type 15.20.2.2. By End User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Service Type 15.21.2.2. By End User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Service Type 15.22.2.2. By End User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Service Type 15.23.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Service Type 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Covance(Labcorp) 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Eurofins Global Central Library 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. PPD Central Lab 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. ICON Central Labs 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Medpace Reference Laboratory 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Q² Solutions 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Barc Lab 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Frontage Labs 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. ACM Global Laboratories 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Celerion 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Central Lab Market
